| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCGA_PANCAN_2018 v0.0 | KRAS |
Lavinia Gordon gene: KRAS was added gene: KRAS was added to TCGA_PANCAN_2018. Sources: TCGA_PANCAN_2018 Mode of inheritance for gene: KRAS was set to Other Phenotypes for gene: KRAS were set to RAS-associated autoimmune leukoproliferative disorder; Noonan syndrome 3 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||